Blog

- DISEASE ADVANCES

Radio waves amp up smell without surgery or chemicals

Our sense of smell is more important than we often realize. It helps us enjoy food, detect danger like smoke or gas leaks, and even affects our memory and emotions. Many people—especially after COVID-19, aging, or brain injury—suffer from a loss of smell. However, there are very few effective treatments, and those that exist often use strong scents or medicines that cause discomfort in patients.

Read More »

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer’s Disease

BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid 42 Ratio, the first blood-based in-vitro diagnostic (IVD) test cleared by the U.S. Food and Drug Administration (FDA) to aid in the diagnosis of Alzheimer’s disease.

Read More »

Bioengineered platform uses bacteria to sneak viruses into tumors

Researchers at Columbia Engineering have built a cancer therapy that makes bacteria and viruses work as a team. In a study published in Nature Biomedical Engineering, the Synthetic Biological Systems Lab shows how their system hides a virus inside a tumor-seeking bacterium, smuggles it past the immune system, and unleashes it inside cancerous tumors.

Read More »

Scientists discover eight new schizophrenia genes

Researchers have discovered eight new genes associated with schizophrenia, in the largest exome-sequencing study of the disorder ever conducted. The breakthrough, made by scientists at the Centre for Neuropsychiatric Genetics and Genomics (CNGG) at Cardiff University, provides new information and improves the understanding and future treatment development for schizophrenia.

Read More »